Canaccord Genuity Group Issues Pessimistic Forecast for Manolete Partners (LON:MANO) Stock Price

Manolete Partners (LON:MANOGet Free Report) had its price target decreased by stock analysts at Canaccord Genuity Group from GBX 172 to GBX 130 in a report issued on Wednesday,Digital Look reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s target price suggests a potential upside of 83.10% from the stock’s current price.

Manolete Partners Stock Performance

MANO stock traded down GBX 19 during mid-day trading on Wednesday, reaching GBX 71. The company had a trading volume of 460,030 shares, compared to its average volume of 75,572. Manolete Partners has a one year low of GBX 65 and a one year high of GBX 118. The stock has a market capitalization of £31.11 million, a P/E ratio of 35.32 and a beta of 0.77. The company has a quick ratio of 6.25, a current ratio of 4.92 and a debt-to-equity ratio of 33.92. The stock’s 50-day simple moving average is GBX 90.51 and its two-hundred day simple moving average is GBX 88.32.

Manolete Partners (LON:MANOGet Free Report) last released its quarterly earnings data on Wednesday, November 19th. The company reported GBX (1.09) earnings per share for the quarter. Manolete Partners had a return on equity of 109.76% and a net margin of 180.12%. Research analysts anticipate that Manolete Partners will post 4.2845258 EPS for the current year.

About Manolete Partners

(Get Free Report)

Manolete Partners Plc is the UK’s leading insolvency litigation financing company which was founded in 2009 by its Chief Executive, Steven Cooklin, a UK Chartered Accountant.

Manolete finances the pursuit of claims through litigation and alternative dispute resolution to produce optimal returns for the creditors of insolvent companies.

See Also

Receive News & Ratings for Manolete Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Manolete Partners and related companies with MarketBeat.com's FREE daily email newsletter.